Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada a) The launch follows Dr. Reddy’s receipt of the Notice of Compliance (NOC) from Health Canada on April 28th, 2026, marking the company’s readiness to serve Canadian patients b) Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada c) Canada is the first G7 country to grant market authorization for generic Semaglutide Injection

#WatchOutFor#StockInNews